The first RCT on vitamin D and cancer in 2007 showed 77% cancer prevention. That was sixteen years ago! If an intervention that costs about $10 a year can safely reduce the risk of cancer by one-third or more, why aren’t we doing anything about it now?

View as Webpage & Print

Read This on Our Website

10% OFF ALL TEST KITS, ALL MONTH LONG!

It's our way of celebrating the awareness of breast cancer PREVENTION

Getting enough vitamin D, omega-3s, magnesium, selenium, and other nutrients can help reduce the risk of breast cancer and improve breast cancer outcomes.


With October focused on breast cancer awareness, GrassrootsHealth continues to educate about the importance of breast cancer prevention and healing with vitamin D (a topic at the roots of why GrassrootsHealth was founded) and other important nutrients. During this month, we are offering everyone


10% OFF HOME BLOOD SPOT TEST KITS

PLUS Get a FREE Copy of Our NEW Breast Cancer Research Summary Chart Booklet


(to be released mid-October, Free copy sent upon release)


Use code BCP23

Hurry! This offer is available now until Tuesday, October 31st, 2023 at 11.59PM PST. Discount not available on T1D Prevention Test Kits.*

GET YOUR TEST KIT AND RESERVE YOUR FREE BOOKLET NOW!


Please support this educational effort by donating to GrassrootsHealth today!

DONATE HERE

Results from the First Randomized Controlled Trials on Vitamin D and Cancer

Dear Carole,


In the video featured below, Keith Baggerly, PhD., MD Anderson Cancer Center, a “cancer researcher and a numbers geek,” discusses the math and science used to determine recommended vitamin D serum levels and supplementation amounts, and where the Institute of Medicine got it wrong.


This presentation was given at the American Public Health Association (APHA) Annual Meeting & Expo in November of 2016, the same conference at which Dr. Joan Lappe presented findings from her randomized controlled trials on vitamin D, calcium, and cancer risk. These results were published in several papers summarized below, including a 2016 paper showing more than 65% cancer prevention with vitamin D levels at or above 40 ng/ml (100 nmol/L).

Watch the Video

An intervention that costs about $10 a year can reduce the risk of cancer by one-third or more…? Why aren’t we doing anything about it now?! He explains in this video.

Watch Now

Video Summary

  • Brief review of the current recommendations for vitamin D and how they were set
  • The IOM set the target vitamin D level at 20 ng/ml (50 nmol/L); the Endocrine Society disagreed and set their target at 30 ng/ml (75 nmol/L)
  • Review of the data used to assess bone health when determining the recommended serum levels, intake, and the mathematical mistakes made
  • Fear from harm at the upper levels due to potential ‘J’ Curve and the “dread of danger overshadowing potential benefits”
  • Where do we actually see toxicity from vitamin D? Explained…

It’s time! Dr. Lappe’s first study in 2007 showed over 65% cancer prevention at that time. That was sixteen years ago!

The First Randomized Controlled Trial on Vitamin D & Cancer

In 2007, Lappe et al. published Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial with results from a four year, population-based, double-blind, randomized, placebo-controlled trial, and data from 1179 healthy postmenopausal women, aged 55 or older. The primary outcome was the reduction of fractures, and the secondary outcome was cancer incidence. The population was white, lived around 41 degrees latitude, and had an average vitamin D level of 29 ng/ml (72 nmol/L). The treatment group took 1100 IU vitamin D and 1400-1500 mg calcium daily. A second group received calcium and a placebo for vitamin D and a third group that received only placebo – no active supplements at all.


For those diagnosed with cancer after the first year, there was a 77% lower risk of cancer in the vitamin D and calcium group than placebo alone (P value <0.005). This group had an average vitamin D serum level of 38 ng/ml (96 nmol/L). This was the first intervention trial that showed that vitamin D can reduce cancer incidence. Unfortunately, since it was not the primary outcome many people in the research community discounted the cancer results of this study.

The First Randomized Controlled Trial Replicated, Published 2017

Lappe replicated her 2007 study with a larger population of 2303 women over a 4 year period using a larger vitamin D dose (2000 IU/day vs 1100 IU/day) with cancer incidence as the primary study endpoint. This new group started with an average vitamin D level of 33 ng/ml (82 nmol/L). Results were published as Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women: A Randomized Clinical Trial in 2017.


When analyzed by treatment group it showed a 30% reduction. When analyzed by serum level, the data showed that participants with a vitamin D level of 55 ng/ml were 35% less likely to get cancer as compared to those with a vitamin D level of 30 ng/ml (P value = 0.03).

Cancer Incidence by Vitamin D Serum Level in a Combined Cohort using D*action Participants

In April 2016, GrassrootsHealth partnered with leading vitamin D and cancer researchers Dr’s Garland, Gorham, Heaney and Lappe to publish Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study, a paper focused on achieved vitamin D serum levels and cancer incidence. Data was combined for women 55 and older from our GrassrootsHealth cohort (N = 1,135, median serum level = 48 ng/ml) and the cohort of a previously published randomized controlled trial (RCT) of vitamin D and calcium supplementation with respect to cancer (Lappe RCT paper; N= 1,169, median serum level = 30 ng/ml). The pooled cohort was analyzed to investigate cancer incidence over time (median = 3.9 years) for all invasive cancers combined, excluding skin cancer.

Using statistical analysis, we found that women with vitamin D serum levels greater than or equal to 40 ng/ml had a 71% lower risk of cancer than women with serum levels less than 20 ng/ml. In the graph you can see that the greatest decrease in risk occurred between about 10 – 40 ng/ml. Calcium did not have any significant effect on cancer risk in this analysis.


71% Lower Incidence Cancer with 25(OH)D ≥40 ng/ml


This second look at the combined data uses a Kaplan Meier curve to clearly illustrate the difference between the proportion of cancer-free participants at the end of the 4 year observation period.

Breast Cancer Risk 78-80% Lower with 25(OH)D ≥60 ng/ml

Few studies have assessed the association between 25(OH)D and breast cancer risk in concentrations >40 ng/ml. A 2017 pooled analysis of Lappe’s two RCTs (2007, N=1129 and 2016, N=2196) and the GrassrootsHealth Cohort (N=1713) aimed to investigate the relationship between 25(OH)D and breast cancer risk across a broad range of 25(OH)D concentrations among women aged ≥55 years. Within the pooled cohort (N=5038), 77 women were diagnosed with breast cancer during the observation periods (median follow-up time: 4.0 years) with an age-adjusted incidence of 512 cases per 100,000 person-years. Cox regression showed that women with 25(OH)D concentrations ≥60 ng/ml had an 80% lower risk of breast cancer than women with concentrations <20 ng/ml, adjusted for age, BMI, smoking status and calcium supplement intake (HR=0.20, P=0.02). This information as presented at the American College of Nutrition Symposium, 2017.

Get FREE access to an eBooklet of these charts and many more, with summaries of the research, when using the code BCP23 for 10% off any purchase during the month of October, 2023!

Take Action Today and Measure Your Levels of the Above – While Contributing to Vitamin D & Breast Cancer Research!

Based on findings from published studies, measuring your levels of vitamin D, magnesium, selenium, and omega-3s may help determine if more of these nutrients might be needed to provide the greatest risk reduction for breast cancer and improve outcomes in the case of a breast cancer diagnosis.


Create your custom home blood spot kit with the following measurements to help determine if you are getting enough of the following nutrients shown to benefit your current or future breast health:


TEST NOW; USE BCP23 for 10% OFF
LinkedIn Share This Email

Participate Today with Your Home Test Kit Order

All purchases support vitamin D research and education. Measure your vitamin D and other important levels at home as part of the D*action project! Create your custom home test kit or choose from our top products below.

Vitamin D & Omegas

o3-ratios-kit-1 image
Purchase Here

Inflammation Panel

inflammation-kit-2 image
Purchase Here

Immune Boost Panel

immune-boost-kit-2 image
Purchase Here
View All Options Here

How Much Vitamin D do YOU Need to Get to 40 ng/ml (100 nmol/L)?

Did you know that everyone responds differently to vitamin D supplement amounts - by up to 6 times!?

Your health could be greatly affected by making sure you have a vitamin D level of at least 40 ng/ml (100 nmol/L). Don't get stuck with low vitamin D levels - learn more about what might affect your level and response to supplementation, and the steps to take through each season to keep levels in your target range.

Already Know Your D Level?  Use the D*calculator to see how much vitamin D you need

Collaborators in Efficacy Research Projects

Children with Diabetes Research Foundation


The mission of CWDRF is to fund research leading to the cure and prevention of Type 1 diabetes. For over 20 years, they have been the venture capitalists of diabetes research, getting new, clinically relevant, innovative research off the ground.


CWDRF is currently funding the D*action Type 1 Diabetes Prevention project with GrassrootsHealth.

Learn More


Sperti Vitamin D Sunlamps


The Sperti Vitamin D Sunlamp, model D/UV-F, provides the special UVB rays needed for your body to produce Vitamin D. It is the only FDA recognized ultraviolet product for Vitamin D production in the human body, and independent studies have verified its effectiveness.


See how it works for you.

Look for our special project enrollment opportunity with Sperti!



Learn More

The Helen Knoll Foundation


The Helen Knoll Foundation (HKF) mission is to prevent breast cancer by empowering young women through risk awareness education, advocacy and access to age appropriate screenings. HKF with GrassrootsHealth is launching the Know YOUR Number campaign to help Stop Breast Cancer Before it Starts by working with local groups to provide vitamin D blood spot testing and project enrollment events.

Learn More

Have a Beautiful and Healthy Day! Onwards,




Carole Baggerly

Founder




Jen Aliano

Director

GrassrootsHealth

315 S. Coast Hwy 101, Suite U-87

Encinitas, CA 92024

(760) 579-8141

Contact Us
Facebook  Twitter  Instagram  YouTube